Wu Jingcheng, Tao Yang, Gu Hongbing, Sui Jian
Clin Lab. 2016;62(5):807-14. doi: 10.7754/clin.lab.2015.150809.
Even within the reference range, thyrotropin (TSH) levels were found to be positively associated with the risk of cardiovascular disease (CVD). However, the underlying mechanism of TSH remains ambiguous. This study investigated the association of TSH with cardiovascular risk factors among healthy Chinese subjects and subjects with unsuspected subclinical hypothyroidism (SCH).
A total of 741 subjects were included in this cross-sectional study. The subjects were grouped into four, including tertile groups for the TSH reference range and an SCH group based on the TSH level. All the participants underwent physical examination and fasting blood analyses to determine the levels of TSH, free thyroxine, free triiodothyronine, plasma glucose, triglycerides (TG), total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), apolipoprotein A1, apolipoprotein B (ApoB), lipoprotein(a), homocysteine (Hcy), and high sensitivity C-reactive protein (hs-CRP).
The TSH subgroups exhibited a significant increasing trend in terms of LDL-C, ApoB, and Hcy levels (p = 0.01, p < 0.01, and p = 0.01, respectively), whereas the HDL-C levels exhibited a decreasing trend (p = 0.03). After adjusting for gender, age, and smoking status, the TSH levels were found to be positively correlated with body mass index, waist circumference, diastolic blood pressure (DBP), and TG, TC, LDL-C, ApoB, Hcy, and hs-CRP levels (p < 0.05 for all), but negatively correlated with the HDL-C levels (p < 0.01). Multiple linear regression analysis showed that the TSH levels were independently positively associated with the female gender (β = 0.21, p < 0.01), DBP (β = 0.14, β = 0.01), and Hcy levels (β = 0.10, p = 0.01), and negatively associated with the HDL-C (β = -0.11, p = 0.01) and FT4 levels (β = -0.15, p < 0.01).
The TSH levels were independently associated with several cardiovascular risk factors in an apparently healthy Chinese population, and thus may increase the risk of CVD.
即使在参考范围内,促甲状腺激素(TSH)水平也被发现与心血管疾病(CVD)风险呈正相关。然而,TSH的潜在机制仍不明确。本研究调查了健康中国受试者和未被怀疑患有亚临床甲状腺功能减退症(SCH)的受试者中TSH与心血管危险因素之间的关联。
本横断面研究共纳入741名受试者。根据TSH水平,将受试者分为四组,包括TSH参考范围的三分位数组和一个SCH组。所有参与者均接受体格检查和空腹血液分析,以测定TSH、游离甲状腺素、游离三碘甲状腺原氨酸、血糖、甘油三酯(TG)、总胆固醇(TC)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)、载脂蛋白A1、载脂蛋白B(ApoB)、脂蛋白(a)、同型半胱氨酸(Hcy)和高敏C反应蛋白(hs-CRP)的水平。
TSH亚组在LDL-C、ApoB和Hcy水平方面呈现出显著的上升趋势(分别为p = 0.01、p < 0.01和p = 0.01),而HDL-C水平呈现出下降趋势(p = 0.03)。在调整性别、年龄和吸烟状况后,发现TSH水平与体重指数、腰围、舒张压(DBP)以及TG、TC、LDL-C、ApoB、Hcy和hs-CRP水平呈正相关(均p < 0.05),但与HDL-C水平呈负相关(p < 0.01)。多元线性回归分析表明,TSH水平与女性性别(β = 0.21,p < 0.01)、DBP(β = 0.14,p = 0.01)和Hcy水平(β = 0.10,p = 0.01)独立正相关,与HDL-C(β = -0.11,p = 0.01)和FT4水平(β = -0.15,p < 0.01)独立负相关。
在明显健康的中国人群中,TSH水平与多种心血管危险因素独立相关,因此可能增加CVD风险。